Feasibility of using Bortezomib-based immunosuppressive approach to deplete anti-AAV antibodies in mice
Research Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Asklepios BioPharmaceutical, Inc.
Start Date
December 1, 2018
End Date
November 30, 2020
Administered By
Pediatrics, Medical Genetics
Awarded By
Asklepios BioPharmaceutical, Inc.
Start Date
December 1, 2018
End Date
November 30, 2020